
Journal Menu
► ▼ Journal Menu-
- Viruses Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
18 January 2024
Viruses | Editor’s Choice Articles in 2023 (I)

“Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines”
by Prasad D. Trivedi, Barry J. Byrne and Manuela Corti
Viruses 2023, 15(12), 2378; https://doi.org/10.3390/v15122378
Available online: https://www.mdpi.com/1999-4915/15/12/2378
“Enhanced Susceptibility to Tomato Chlorosis Virus (ToCV) in Hsp90- and Sgt1-Silenced Plants: Insights from Gene Expression Dynamics”
by Irene Ontiveros, Noé Fernández-Pozo, Anna Esteve-Codina, Juan José López-Moya and Juan Antonio Díaz-Pendón
Viruses 2023, 15(12), 2370; https://doi.org/10.3390/v15122370
Available online: https://www.mdpi.com/1999-4915/15/12/2370
“The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic”
by Brittany A. Comunale, Robin J. Larson, Erin Jackson-Ward, Aditi Singh, Frances L. Koback and Lilly D. Engineer
Viruses 2023, 15(12), 2316; https://doi.org/10.3390/v15122316
Available online: https://www.mdpi.com/1999-4915/15/12/2316
“An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding”
by Haiyan Wang, Benoit Gallet, Christine Moriscot, Mylène Pezet, Christine Chatellard, Jean-Philippe Kleman, Heinrich Göttlinger, Winfried Weissenhorn and Cécile Boscheron
Viruses 2023, 15(12), 2289; https://doi.org/10.3390/v15122289
Available online: https://www.mdpi.com/1999-4915/15/12/2289
“Identification of Host Factors for Rift Valley Fever Phlebovirus”
by Velmurugan Balaraman, Sabarish V. Indran, Yonghai Li, David A. Meekins, Laxmi U. M. R. Jakkula, Heidi Liu, Micheal P. Hays, Jayme A. Souza-Neto, Natasha N. Gaudreault, Philip R. Hardwidge et al.
Viruses 2023, 15(11), 2251; https://doi.org/10.3390/v15112251
Available online: https://www.mdpi.com/1999-4915/15/11/2251
“Nanoluciferase Reporter Zika Viruses as Tools for Assessing Infection Kinetics and Antibody Potency”
by Yanqun Xu, Devin Vertrees, Yong He, Sanaz Momben-Abolfath, Xiaohong Li, Yambasu A. Brewah, Dorothy E. Scott, Krishnamurthy Konduru, Maria Rios and Evi B. Struble
Viruses 2023, 15(11), 2190; https://doi.org/10.3390/v15112190
Available online: https://www.mdpi.com/1999-4915/15/11/2190
“Pteropus vampyrus TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors”
by Sarah van Tol, Adam Hage, Ricardo Rajsbaum and Alexander N. Freiberg
Viruses 2023, 15(11), 2147; https://doi.org/10.3390/v15112147
Available online: https://www.mdpi.com/1999-4915/15/11/2147
“Diversity and Current Classification of dsRNA Bacteriophages”
by Sari Mäntynen, Meri M. Salomaa and Minna M. Poranen
Viruses 2023, 15(11), 2154; https://doi.org/10.3390/v15112154
Available online: https://www.mdpi.com/1999-4915/15/11/2154
“A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protect Pigs against a Virulent CSFV Challenge”
by Ediane Silva, Elizabeth Medina-Ramirez, Selvaraj Pavulraj, Douglas P. Gladue, Manuel Borca and Shafiqul I. Chowdhury
Viruses 2023, 15(11), 2143; https://doi.org/10.3390/v15112143
Available online: https://www.mdpi.com/1999-4915/15/11/2143
“Polyomavirus Wakes Up and Chooses Neurovirulence”
by Arrienne B. Butic, Samantha A. Spencer, Shareef K. Shaheen and Aron E. Lukacher
Viruses 2023, 15(10), 2112; https://doi.org/10.3390/v15102112
Available online: https://www.mdpi.com/1999-4915/15/10/2112
“Small Heat Shock Protein (sHsp22.98) from Trialeurodes vaporariorum Plays Important Role in Apple Scar Skin Viroid Transmission”
by Savita Chaudhary, Vijayanandraj Selvaraj, Preshika Awasthi, Swati Bhuria, Rituraj Purohit, Surender Kumar and Vipin Hallan
Viruses 2023, 15(10), 2069; https://doi.org/10.3390/v15102069
Available online: https://www.mdpi.com/1999-4915/15/10/2069
10 January 2024
Viruses Papers Released in 2023 Receive “Highly Cited Papers” Distinction in Web of Science
As of July/August 2023, 16 papers from Viruses (ISSN: 1999-4915) released in 2023 received enough citations to place them in the top 1% of the academic field of microbiology based on a highly cited threshold for the field and publication year.
The Viruses Editorial Office sincerely congratulates all the authors and hopes that they continue to have an academically productive relationship with the journal.
“Decreased Clinical Severity of Pediatric Acute COVID-19 and MIS-C and Increase of Incidental Cases during the Omicron Wave in Comparison to the Delta Wave”
by Patrick O. Kenney, Arthur J. Chang, Lorna Krabill and Mark D. Hicar
Viruses 2023, 15(1), 180; https://doi.org/10.3390/v15010180
“Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study”
by Maria Mazzitelli, Daniele Mengato, Lolita Sasset, Anna Ferrari, Samuele Gardin, Vincenzo Scaglione, Nicola Bonadiman, Lucrezia Calandrino, Silvia Cavinato, Sabrina Trivellato et al.
Viruses 2023, 15(2), 384; https://doi.org/10.3390/v15020384
“Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression”
by Andrea De Vito, Agnese Colpani, Laura Saderi, Mariangela Puci, Beatrice Zauli, Vito Fiore, Marco Fois, Maria Chiara Meloni, Alessandra Bitti, Cosimo Di Castri et al.
Viruses 2023, 15(1), 71; https://doi.org/10.3390/v15010071
“Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience”
by Karolina Akinosoglou, Emmanouil-Angelos Rigopoulos, Georgia Kaiafa, Stylianos Daios, Eleni Karlafti, Eleftheria Ztriva, Georgios Polychronopoulos, Charalambos Gogos and Christos Savopoulos
Viruses 2023, 15(1), 118; https://doi.org/10.3390/v15010118
“TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection”
by Kristin Metzdorf, Henning Jacobsen, Marina C. Greweling-Pils, Markus Hoffmann, Tatjana Lüddecke, Felicitas Miller, Lars Melcher, Amy M. Kempf, Inga Nehlmeier, Dunja Bruder et al.
Viruses 2023, 15(2), 271; https://doi.org/10.3390/v15020271
“Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment”
by Aydin Huseynov, Ibrahim Akin, Daniel Duerschmied and Rüdiger E. Scharf
Viruses 2023, 15(2), 389; https://doi.org/10.3390/v15020389
“Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database”
by Robert Flisiak, Piotr Rzymski, Dorota Zarębska-Michaluk, Przemysław Ciechanowski, Krystyna Dobrowolska, Magdalena Rogalska, Jerzy Jaroszewicz, Anna Szymanek-Pasternak, Marta Rorat, Dorota Kozielewicz et al.
Viruses 2023, 15(1), 149; https://doi.org/10.3390/v15010149
“Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5”
by Carolina Torres, Mercedes Nabaes Jodar, Dolores Acuña, Romina Micaela Zambrana Montaño, Andrés Carlos Alberto Culasso, Ariel Fernando Amadio, Paula Aulicino, Santiago Ceballos, Marco Cacciabue, Humberto Debat et al.
Viruses 2023, 15(2), 312; https://doi.org/10.3390/v15020312
“Hyperinflammatory Response in COVID-19: A Systematic Review”
by Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Maria Isabel Montoril Gouveia, Beatriz dos Reis Marcelino, Carolynne Silva dos Santos, Karla Valéria Batista Lima and Luana Nepomuceno Gondim Costa Lima
Viruses 2023, 15(2), 553; https://doi.org/10.3390/v15020553
“The Role of Viral Infections in the Onset of Autoimmune Diseases”
by Bhargavi Sundaresan, Fatemeh Shirafkan, Kevin Ripperger and Kristin Rattay
Viruses 2023, 15(3), 782; https://doi.org/10.3390/v15030782
“Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID”
by Aristo Vojdani, Elroy Vojdani, Evan Saidara and Michael Maes
Viruses 2023, 15(2), 400; https://doi.org/10.3390/v15020400
“A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies”
by Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, Kuldeep Dhama and Chiranjib Chakraborty
Viruses 2023, 15(1), 167; https://doi.org/10.3390/v15010167
“Epizootic Haemorrhagic Disease Virus Serotype 8 in Tunisia, 2021”
by Soufien Sghaier, Corinne Sailleau, Maurilia Marcacci, Sarah Thabet, Valentina Curini, Thameur Ben Hassine, Liana Teodori, Ottavio Portanti, Salah Hammami, Lucija Jurisic et al.
Viruses 2023, 15(1), 16; https://doi.org/10.3390/v15010016
“Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors”
by Levente Zsichla and Viktor Müller
Viruses 2023, 15(1), 175; https://doi.org/10.3390/v15010175
“Pediatric Systemic Lupus Erythematous in COVID-19 Era”
by Ancuta Lupu, Ingrith Crenguta Miron, Cristina Gavrilovici, Anca Adam Raileanu, Iuliana Magdalena Starcea, Ileana Ioniuc, Alice Azoicai, Adriana Mocanu, Lacramioara Ionela Butnariu, Felicia Dragan et al.
Viruses 2023, 15(2), 272; https://doi.org/10.3390/v15020272
“Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus”
by Yasir Ali, Hina Imtiaz, Muhammad Mutaal Tahir, Fouzia Gul, Umair Ali Khan Saddozai, Ashfaq ur Rehman, Zhi-Guang Ren, Saadullah Khattak and Xin-Ying Ji
Viruses 2023, 15(2), 570; https://doi.org/10.3390/v15020570
2 January 2024
MDPI Insights: The CEO's Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Nobel Prize Laureates Entrust MDPI with Their Research
The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.
Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, Pharmaceutics, Photonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.
The best of the best trust us with their work.
Nobel Prize Laureates Who Have Published with MDPI
We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.
The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.
2023 Nobel Prize Winners Published by MDPI
Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)
Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.
In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.
Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".
We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.
Read more:
Impactful Research
MDPI Journals Newly Indexed in 2023
The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.
Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.
In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.
The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.
MDPI’s journals are indexed in all major global databases.
Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.
Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)
Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.
Read more:
Inside MDPI
MDPI Appoints New Chief Operating Officer (COO)
Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.
Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.
As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.
Coming Together for Science
MDPI’s 2024 In-Person Academic Events Schedule
MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.
Here's a glimpse of the notable events we currently have scheduled for 2024:
|
14–16 February, 2024 |
|
24–26 April, 2024 |
|
28–31 May, 2024 |
|
1–4 August, 2024 |
Upcoming events with details to be announced:
- September 2024, Materials 2024 – Basel, Switzerland
- 19–21 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
- October 2024, ncRNA 2024 – Basel, Switzerland
- November 2024, Pharmaceuticals 2024 – Barcelona, Spain
- 22–26 November 2024, International Conference on Science of Electronics – Wuhan, China
- Stay tuned for more details on the Sustainable Publishing Forum 2024.
Click here for all upcoming MDPI events.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
Reflecting on 2023 and Looking Ahead to 2024
As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.
Becoming a stronger organisation
While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.
I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.
“I am committed to taking MDPI to a new level of excellence.”
Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.
Accountability and communication
As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.
Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.
Here’s to a joyous and prosperous 2024!
Chief Executive Officer
MDPI AG
7 December 2023
Viruses | Collection of Papers by Chinese Academicians

“Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins”
by Jing Zhang, Yongxiang Wang, Shuwen Fu, Quan Yuan, Qianru Wang, Ningshao Xia, Yumei Wen, Jisu Li and Shuping Tong
Viruses 2021, 13(4), 613; https://doi.org/10.3390/v13040613
Available online: https://www.mdpi.com/1999-4915/13/4/613
“Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region”
by Junping Hong, Dongmei Wei, Qian Wu, Ling Zhong, Kaiyun Chen, Yang Huang, Wanlin Zhang, Junyu Chen, Ningshao Xia, Xiao Zhang et al.
Viruses 2021, 13(12), 2380; https://doi.org/10.3390/v13122380
Available online: https://www.mdpi.com/1999-4915/13/12/2380
“A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection”
by Dian Zeng, Jiabao Xin, Kunyu Yang, Shuxin Guo, Qian Wang, Ying Gao, Huiqing Chen, Jiaqi Ge, Zhen Lu, Limin Zhang et al.
Viruses 2022, 14(6), 1305; https://doi.org/10.3390/v14061305
Avaliable online: https://www.mdpi.com/1999-4915/14/6/1305
“Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice”
by Wenhui Xue, Tingting Li, Sibo Zhang, Yingbin Wang, Minqing Hong, Lingyan Cui, Hong Wang, Yuyun Zhang, Tingting Chen, Rui Zhu et al.
Viruses 2022, 14(8), 1785; https://doi.org/10.3390/v14081785
Available online: https://www.mdpi.com/1999-4915/14/8/1785
“An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease”
by Min Lin, Wei Zhang, Yi-Fan Yin, Jun-Yu Si, Lu-Jing Zhang, Li Chen, Xue Lin, Ying-Bin Wang, Jun Zhang, Zi-Zheng Zheng et al.
Viruses 2022, 14(10), 2085; https://doi.org/10.3390/v14102085
Available online: https://www.mdpi.com/1999-4915/14/10/2085
“A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity”
by Zihao Chen, Shaoqi Guo, Guanghui Li, Dong Ying, Guiping Wen, Mujin Fang, Yingbin Wang, Zimin Tang, Zizheng Zheng and Ningshao Xia
Viruses 2022, 14(10), 2122; https://doi.org/10.3390/v14102122
Available online: https://www.mdpi.com/1999-4915/14/10/2122
“Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections”
by Yang Shi, Zihan Wang, Shengxiang Ge, Ningshao Xia and Quan Yuan
Viruses 2023, 15(5), 1111; https://doi.org/10.3390/v15051111
Available online: https://www.mdpi.com/1999-4915/15/5/1111
“3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In Vivo”
by Xuejin Zhao, Lianzhong Zhao, Ya Zhao, Kun Huang, Wenxiao Gong, Ying Yang, Li Zhao, Xiaohan Xia, Zaiyun Li, Feng Sheng et al.
Viruses 2021, 13(8), 1433; https://doi.org/10.3390/v13081433
Available online: https://www.mdpi.com/1999-4915/13/8/1433
“Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies”
by Hakimeh Baghaei Daemi, Muhammad Fakhar-e-Alam Kulyar, Xinlin He, Chengfei Li, Morteza Karimpour, Xiaomei Sun, Zhong Zou and Meilin Jin
Viruses 2021, 13(6), 1145; https://doi.org/10.3390/v13061145
Available online: https://www.mdpi.com/1999-4915/13/6/1145
“A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern”
by Qiaoshuai Lan, Jasper Fuk-Woo Chan, Wei Xu, Lijue Wang, Fanke Jiao, Guangxu Zhang, Jing Pu, Jie Zhou, Shuai Xia, Lu Lu et al.
Viruses 2022, 14(3), 549; https://doi.org/10.3390/v14030549
Available online: https://www.mdpi.com/1999-4915/14/3/549
“Characterization of the Novel Phage vB_VpaP_FE11 and Its Potential Role in Controlling Vibrio parahaemolyticus Biofilms”
by Meiyan Yang, Hanfang Chen, Qiaolan Huang, Zhuanbei Xie, Zekun Liu, Jumei Zhang, Yu Ding, Moutong Chen, Liang Xue, Qingping Wu et al.
Viruses 2022, 14(2), 264; https://doi.org/10.3390/v14020264
Available online: https://www.mdpi.com/1999-4915/14/2/264
“The Epidemiology and Variation in Pseudorabies Virus: A Continuing Challenge to Pigs and Humans”
by Qingyun Liu, Yan Kuang, Yafei Li, Huihui Guo, Chuyue Zhou, Shibang Guo, Chen Tan, Bin Wu, Huanchun Chen and Xiangru Wang
Viruses 2022, 14(7), 1463; https://doi.org/10.3390/v14071463
Available online: https://www.mdpi.com/1999-4915/14/7/1463
6 December 2023
Editorial Board Members from Viruses Featured in the 2023 Highly Cited Researchers List Published by Clarivate

Recently, Clarivate™ revealed its 2023 list of Highly Cited Researchers™—individuals at universities, research institutes, and commercial organizations.
The scientists who were selected for this year’s list of Highly Cited Researchers published highly cited papers in the 11-year period from January 2012 to December 2022, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of Science™ database. This year, 7125 Highly Cited Researcher 2023 designations were issued to 6849 individuals, representing just 1 in 1000 researchers worldwide. This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. The list is truly global, spanning 67 countries or regions and spread across a diverse range of research sciences and social sciences.
According to our statistics, six members of the Editorial Board of Viruses (ISSN: 1999-4915) were selected for the list of Highly Cited Researchers by Clarivate™ in 2023. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. Viruses Editorial Office sincerely congratulates all elected editorial members and hopes that they continue to have an academically productive relationship with the journal.
Researcher |
Category |
Affiliation |
Kuhn, Jens H. |
Microbiology |
National Institutes of Health (NIH)-USA, United States |
Lan, Ke |
Microbiology |
Wuhan University, China |
Jiang, Shibo |
Microbiology |
Fudan University, China |
Perlman, Stanley |
Immunology |
University of Iowa, United States |
Pöhlmann, Stefan |
Molecular Biology and Genetics |
Deutsches Primatenzentrum (DPZ), Germany |
Chen, Yu |
Microbiology |
Wuhan University, China |
30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Spain Summit
Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.
On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.
With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.
The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.
The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.
Connecting with Editorial Board Members
Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."
Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.
From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.
As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.
Open Access in Spain
In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.
For further details of Spain's OA policy and the history of government mandates, click here.
Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus.
A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!
MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.
I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.
Impactful Research
769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023
Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.
Click here to view the full list of 769 Editorial Board Members.
Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.
Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!
Inside MDPI
Corporate Marketing and Communications Strategy Session
Members of MDPI’s Corporate Marketing & Communications team.
For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.
This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.
We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.
The strategy session also serves as a team-building activity, during which the team voted on bowling!
Strategy Session
In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.
To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.
I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.
Coming Together for Science
ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home
Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.
When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.
In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.
While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.
The press release below provides further details.
Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023
ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.
This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.
Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.
Closing Thoughts
November is Men’s Health Awareness Month
Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.
November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.
I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.
Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.
Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.
Healthy men help build healthy families and a healthy society
Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.
From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.
Mindfulness
Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:
Chief Executive Officer
MDPI AG
21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023

We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.
Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!
Abate, Antonio |
Jaiswal, Amit K. |
Shen, Zexiang |
16 November 2023
Advancing Our Understanding of Viruses: Essential High-Impact Articles by Leading Experts

We are thrilled to showcase a collection of high-impact articles recently published in Viruses (ISSN: 1999-4915). These articles, authored by renowned experts in the field, offer profound insights into various aspects of virology, contributing significantly to our understanding of viruses and their implications. Explore these groundbreaking contributions below:
“Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2”
by Yuko Sakai-Tagawa, Seiya Yamayoshi, Peter J. Halfmann and Yoshihiro Kawaoka
Viruses 2021, 13(11), 2183; https://doi.org/10.3390/v13112183
Available online: https://www.mdpi.com/1999-4915/13/11/2183
“Jumbo Phages: A Comparative Genomic Overview of Core Functions and Adaptions for Biological Conflicts”
by Lakshminarayan M. Iyer, Vivek Anantharaman, Arunkumar Krishnan, A. Maxwell Burroughs and L. Aravind
Viruses 2021, 13(1), 63; https://doi.org/10.3390/v13010063
Available online: https://www.mdpi.com/1999-4915/13/1/63
“The Advantages and Challenges of Using Endolysins in a Clinical Setting”
by Ellen Murray, Lorraine A. Draper, R. Paul Ross and Colin Hill
Viruses 2021, 13(4), 680; https://doi.org/10.3390/v13040680
Available online: https://www.mdpi.com/1999-4915/13/4/680
“Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs”
by Steven J. Smith, Xue Zhi Zhao, Dario Oliveira Passos, Dmitry Lyumkis, Terrence R. Burke and Stephen H. Hughes
Viruses 2021, 13(2), 205; https://doi.org/10.3390/v13020205
Available online: https://www.mdpi.com/1999-4915/13/2/205
“The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2”
by Javed Akhter, Grégory Quéromès, Krishna Pillai, Vahan Kepenekian, Samina Badar, Ahmed H. Mekkawy, Emilie Frobert, Sarah J. Valle and David L. Morris
Viruses 2021, 13(3), 425; https://doi.org/10.3390/v13030425
Available online: https://www.mdpi.com/1999-4915/13/3/425
“HIV Capsid and Integration Targeting”
by Alan N. Engelman
Viruses 2021, 13(1), 125; https://doi.org/10.3390/v13010125
Available online: https://www.mdpi.com/1999-4915/13/1/125
“HIV-1: To Splice or Not to Splice, That Is the Question”
by Ann Emery and Ronald Swanstrom
Viruses 2021, 13(2), 181; https://doi.org/10.3390/v13020181
Available online: https://www.mdpi.com/1999-4915/13/2/181
“Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19”
by Eli Mansour, Andre C. Palma, Raisa G. Ulaf, Luciana C. Ribeiro, Ana Flavia Bernardes, Thyago A. Nunes, Marcus V. Agrela, Bruna Bombassaro, Milena Monfort-Pires, Rafael L. Camargo et al.
Viruses 2021, 13(2), 309; https://doi.org/10.3390/v13020309
Available online: https://www.mdpi.com/1999-4915/13/2/309
“Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective”
by Colin D. Funk, Craig Laferrière and Ali Ardakani
Viruses 2021, 13(3), 418; https://doi.org/10.3390/v13030418
Available online: https://www.mdpi.com/1999-4915/13/3/418
These articles represent significant contributions to the field of virology, providing valuable insights for researchers and enthusiasts alike. Stay updated with the latest developments in virology by exploring these publications.
Thank you for your continued support of Viruses. We anticipate sharing more groundbreaking research with you in the future.
1 November 2023
MDPI Insights: The CEO's Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week 2023 – the Global Drive to Open Continues
As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.
International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.
Core principles of OA publishing
Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.
One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.
OA holds the potential to democratize knowledge, advance science, and drive positive societal change.
Policy driving change
Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the US, EU and China.
OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to lead the transition to open access.
Read more:
Impactful Research
Spotlight on Smart Cities
Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.
As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.
Highly cited papers in Smart Cities
Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.
1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities”
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.
2. “A Review on Electric Vehicles: Technologies and Challenges”
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.
3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges”
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.
4. “Artificial Intelligence Techniques in Smart Grid: A Survey”
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.
5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures”
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.
Testimonial
“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators.” – Dr. Luís Rosa, University of Minho
Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility
Inside MDPI
MDPI Manchester office, UK Visit
Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.
In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.
Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.
I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.
The UK by numbers
The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.
As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.
According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.
We are currently hiring EEs in various locations worldwide.
English Editing at MDPI
Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.
While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.
Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.
Testimonials
“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam
“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño
Read more:
Coming Together for Science
STM and Frankfurt Book Fair
Attending STM
MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.
Meeting with Web of Science
On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.
“We discussed ways to improve our communication and collaboration.”
I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.
75th Frankfurt Book Fair
Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.
For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.
MDPI Books
Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?
The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.
If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.
Closing Thoughts
MDPI Strategy Meeting
As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.
Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.
“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”
As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!
Chief Executive Officer
MDPI AG
19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues

MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.
In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!
Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.
The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.
Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.
Promoting the values of accessibility, transparency, and collaboration
Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations.
Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways.
One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges.
Funders' policies are getting aligned with open science
Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the US, EU and China.
Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to be a leader in the transition to open access.